Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• ‘A potent medicine’: In matters of pain and trust, empathy may make all the difference Rob Volansky
• Empathy and symptom control in rheumatology practice: Time to get real Leonard H. Calabrese, DO
• Rheumatologists ‘must acknowledge the real-world need’ to understand medical cannabis use Rob Volansky
• ACA contraception coverage increases birth control use, lowers pregnancy, abortion rates Erin T. Welsh, MA
• ACR recommends triple therapy for lupus nephritis in new 2024 guidelines Rob Volansky
• ACR urges congressional leaders to reform ‘underwater’ biosimilar reimbursement
• Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease Rob Volansky
• ‘Beyond doubt’: B-cell depletion with inebilizumab reduces flare risk in IgG4-RD Justin Cooper
• Black children with lupus have higher disease activity, less likely to achieve low activity Justin Cooper
• Dapirolizumab pegol superior to placebo, may represent a ‘novel treatment’ for lupus Rob Volansky
• Deucravacitinib superior to placebo for achieving psoriatic arthritis MDA at 16 weeks Justin Cooper
• FDA approves Yesintek, sixth Stelara biosimilar; launch slated for February
• FDA grants breakthrough therapy designation to nipocalimab for Sjögren’s disease
• FDA grants rare pediatric disease designation to treatment for systemic JIA flares
• Hand, whole-body MRI register joint, enthesis improvements from apremilast in PsA Justin Cooper
• Infliximab bests cyclophosphamide as first-line treatment of severe Behçet’s syndrome Justin Cooper
• Lorecivivint may be the ‘first disease-modifying treatment’ for knee osteoarthritis Rob Volansky
• Low IL-18 levels may predict long COVID risk in systemic autoimmune rheumatic diseases Rob Volansky
• More than half of pediatric rheumatology fellowship slots unfilled on Match Day 2024
• Name changes for Sjögren’s, axial spondyloarthritis ‘a big deal’ for researchers, patients Justin Cooper
• New EULAR systemic sclerosis recommendations illuminate a ‘significantly changed’ field Justin Cooper
• Nipocalimab bests placebo, ‘justifies further development’ in Sjögren’s disease Rob Volansky
• Patients ‘very skilled’ at monitoring own non-musculoskeletal psoriatic arthritis features Justin Cooper
• Policies that restrict fast-food outlets may reduce childhood obesity in deprived areas Moira Mahoney
• Post-exertional malaise assessment ‘becoming more important’ for long COVID in rheum care Rob Volansky
• Prior surgery has no impact on exercise therapy, education outcomes in knee osteoarthritis Justin Cooper
• Severe infection, rituximab use predict long COVID in patients with autoimmune disease Rob Volansky
• ‘Stay popular, stay full’: ACR tackles workforce shortage through reimbursement, education Rob Volansky
• Weight loss with semaglutide reduces pain, improves function in knee osteoarthritis Justin Cooper
• Withholding JAK, IL-17 inhibitors fails to improve COVID-19 vaccine booster response Rob Volansky